Log in to search using one of your social media accounts:


7 medtech stories we missed this week: August 11, 2017

[Image from unsplash.com]From Xtant Medical’s 510(k) extension to Varian Medical’s distribution deal, here are seven medtech stories we missed this week but thought were still worth a mention. 1. FDA extends Xtant Medical’s 510(k) for Calix C spinal implant Xtant Medical announced in an Aug. 9 press release that the FDA has cleared its product line extensions for the Calix-C cervical inter body cages. The clearance allows for two larger footprints to be added for use with allograft. The Calix-C Cervical Interbody Spacer is designed for spinal fusion procedures at level one in patients who are skeletally mature. It is supposed to be used with spinal fixation systems like Xtant Medical’s Spider Cervical Plating and Certex Spinal Fixation Systems. 2. Life Spine touts first use of TiBow spacer Life Spine has announced the first clinical use of its TiBow MIS TLIF Expandable Spacer System with Osseo Loc Surface Technology in an Aug. 8 press release. TiBow is designed for in-situ expansion for increased endplate coverage and stability for minimally invasive TLIF and oblique approaches. It gives the surgeon the ability to restore sagittal alignment. 3. Cardiac Science inks deal to supply AEDs to Philadelphia schools Cardiac Science announced in an Aug. 8 press release that it has reached a deal with the School District of Philadelphia to make automated external defibrillators (AEDs) available in all 220 Philadelphia schools. Philadelphia’s high...
Source: Mass Device - Category: Medical Devices Authors: Tags: 510(k) Cardiovascular Clinical Trials Food & Drug Administration (FDA) Oncology Regulatory/Compliance Spinal Surgical Apifix Cardiac Science Hip Innovation Life Spine Inc. MedTech Pentax Medical Varian Medical Systems Xtant M Source Type: news

Related Links:

ConclusionsThe expression of N-cadherin in metastatic lymph nodes is useful for predicting the prognosis of patients with gastric cancer. The Snail switch —namely, the positive-to-negative conversion of the Snail status—between primary tumors and lymph node metastasis may be important for confirming EMT and mesenchymal–epithelial transition.
Source: Gastric Cancer - Category: Gastroenterology Source Type: research
ConclusionsDNA CY1 detected by Q-MSP forCDO1 gene promoter DNA methylation has a great potential to detect minimal residual disease of the peritoneum in GC clinics as a novel DNA marker.
Source: Gastric Cancer - Category: Gastroenterology Source Type: research
OESOPHAGEAL cancer - or cancer of the gullet - could be treated with a existing drug in a new way, experts have found.
Source: Daily Express - Health - Category: Consumer Health News Source Type: news
NEW YORK (Reuters) - A massive California verdict in a lawsuit alleging Johnson&Johnson's talc-based products cause cancer has opened a new front in the litigation, upending the company's hopes that the cases were only gaining traction in Missouri, legal experts said.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
This article is protected by copyright. All rights reserved.
Source: International Journal of Cancer - Category: Cancer & Oncology Authors: Tags: Research Article Source Type: research
We report a series of eight patients with adverse reactions to VCR over the course of 11 months at a single institution, four of which progressed to anaphylaxis and one of which resulted in cardiac arrest. Mass spectrometry analysis of medication lots was performed to test for possible contaminant(s). Our findings highlight the risk of anaphylaxis during therapy with VCR.
Source: Pediatric Blood and Cancer - Category: Cancer & Oncology Authors: Tags: BRIEF REPORT Source Type: research
CONCLUSIONSEvidence of low distress during the time of cancer screening suggests that distress might not be a widespread barrier to screening among adults who undergo screening. However, more studies are needed using validated measures of distress to further understand the extent to which screening may elicit psychological distress and impede adherence to national screening recommendations. Cancer 2017. © 2017 American Cancer Society.
Source: Cancer - Category: Cancer & Oncology Authors: Tags: Review Article Source Type: research
(Reuters Health) - People who decide to tackle their cancer using only unconventional methods are likely to die sooner than patients who opt for conventional treatments, according to a new study.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
Increased odds only seemed to affect men or male smokers, study suggests
Source: The Doctors Lounge - Oncology - Category: Cancer & Oncology Tags: Oncology, Reproductive Medicine, Nutrition, Preventive Medicine, News, Source Type: news
A Los Angeles jury that agreed there was a connection between a woman ’s use of Johnson&Johnson talcum powder products and her terminal ovarian cancer have awarded the woman $417 million in compensatory and punitive damages. Eva Echeverria, 63, was unable to attend the trial because of her illness, but said in a recorded deposition that she used Johnson’s Baby Powder from age 11 until 2016. She was diagnosed with ovarian cancer in 2007 and is now near death, the Los Angeles Times reported. There…
Source: bizjournals.com Health Care:Physician Practices headlines - Category: American Health Authors: Source Type: news
More News: Anatomy | Australia Health | Back Curves | Bone Graft | Brachytherapy | Cancer | Cancer & Oncology | Cancer in Adolescents | Cardiology | Cardiovascular | Cardiovascular & Thoracic Surgery | Cervical Cancer | Clinical Trials | Endoscopy | Esophagus Cancer | Heart | Men | Radiation Therapy | Rectal Cancers | Science | Scoliosis | Study | Ultrasound | Upper Endoscopy